Retrospective Study of Brachytherapy

NCT05242861RecruitingOBSERVATIONAL

Summary

Brachytherapy for gynecological cancers will be studied retrospectively.

Key Facts

Lead Sponsor

Zhejiang Cancer Hospital

Enrollment

300

Start Date

2022-02-20

Completion Date

2024-12-31

Study Type

OBSERVATIONAL

Official Title

A Retrospective Study of Brachytherapy in Gynecological Cancers

Interventions

Brachytherapy

Conditions

BrachytherapyUterine Cervical NeoplasmsUterine NeoplasmsVulvar CancerVaginal CancerOvarian NeoplasmsGynecologic Neoplasm

Eligibility

Age Range

18 Years – 80 Years

Sex

FEMALE

Inclusion Criteria:

* 18 - 80 female
* Underwent brachytherapy
* With gynecological cancer

Exclusion Criteria:

* Refusal to enter this trial

Outcome Measures

Primary Outcomes

Overall survival rate

the percentage of participants in the group who survives

Time frame: 5-year

Secondary Outcomes

Progression-free survival rate

the percentage of participants in the group whose disease is likely to remain stable

Time frame: 5-year

Side effects

side effects associated with treatment

Time frame: 5-year

Locations

Zhejiang Cancer Hospital, Hangzhou, China

Linked Diseases

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms — a type of gynecological cancer.

Uterine Neoplasms

Uterine Neoplasms — a type of gynecological cancer.

Ovarian Neoplasms

Ovarian Neoplasms — a type of gynecological cancer.

Retrospective Study of Brachytherapy